Altrafin AG’s Franco-Nevada FNV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-14,036
Closed -$1.74M 50
2024
Q3
$1.74M Sell
14,036
-25,355
-64% -$3.14M 0.63% 33
2024
Q2
$4.67M Hold
39,391
1.72% 19
2024
Q1
$4.69M Buy
39,391
+25
+0.1% +$2.75K 1.7% 21
2023
Q4
$4.36M Buy
39,366
+866
+2% +$105K 1.68% 23
2023
Q3
$5.14M Buy
38,500
+6,605
+21% +$934K 2.24% 18
2023
Q2
$4.55M Sell
31,895
-2,990
-9% -$449K 2.04% 17
2023
Q1
$5.09M Buy
34,885
+60
+0.2% +$8.37K 2.5% 12
2022
Q4
$4.75M Buy
34,825
+375
+1% +$49.5K 2.78% 11
2022
Q3
$4.12M Buy
34,450
+300
+0.9% +$37.7K 2.47% 14
2022
Q2
$4.49M Sell
34,150
-3,500
-9% -$518K 2.42% 12
2022
Q1
$6.01M Sell
37,650
-17,390
-32% -$2.5M 2.36% 12
2021
Q4
$7.61M Buy
+55,040
New +$7.61M 2.75% 9

Other funds holding FNV

Altrafin AG's FNV Position: Q4 2024 in Review

Altrafin AG sold out of Franco-Nevada (FNV) in Q4 2024, closing a stake of 14,036 shares — an estimated $1.74M sold.

Altrafin AG first reported a position in FNV in Q4 2021 and held it in 12 quarters. The position peaked at $7.61M in Q4 2021. 485 funds tracked by Wall St. Rank hold FNV as of Q4 2024.

  • Altrafin AG reported no remaining Franco-Nevada position as of Q4 2024 after selling out during the quarter.
  • Altrafin AG sold 14,036 Franco-Nevada shares in Q4 2024, an estimated $1.74M.
  • Altrafin AG first reported a position in Franco-Nevada in Q4 2021 and held it in 12 quarters.
  • Altrafin AG's Franco-Nevada position peaked at $7.61M in Q4 2021.
  • 485 funds tracked by Wall St. Rank held Franco-Nevada as of Q4 2024.

Based on Altrafin AG's 13F filing for Q4 2024, filed 17 Feb 2026.